We are live on !
Find out more
CC
Caxton Corporation Portfolio holdings
AUM
$1.85M
Turnover
45.45%
1-Year Est. Return
176.16%
This Fund
S&P 500
This Quarter Est. Return
+9.05%
1 Year Est. Return
+176.16%
3 Year Est. Return
+511.75%
5 Year Est. Return
+854.95%
10 Year Est. Return
+8,566.11%
AUM
$1.85M
AUM Growth
-$2.17M
(-54%)
Cap. Flow
-$2.64M
Cap. Flow % of AUM
Cap. Flow %
-142.5%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
4
Increased
2
Reduced
1
Closed
1
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
0.9
years
Top 20 Avg Time Held
Equity + Options
1
year
Avg Time Held Equity only
1.1
years
Top 10 Avg Time Held Equity only
1
year
Top 20 Avg Time Held Equity only
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$249K |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$226K |
| 3 |
Blackstone
BX
|
+$192K |
| 4 |
Lexeo Therapeutics
LXEO
|
+$16.3K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$13K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$3.28M |
| 2 |
Kyverna Therapeutics
KYTX
|
+$57K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.6% |
| 2 | Financials | 30.5% |
| 3 | Healthcare | 19.57% |
| 4 | Communication Services | 13.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
SpaceX
SPCX
$1.95T
| $445K | 24.03% |
+2,606
| New | +$443K |
2026 Q2
0 quarters
|
|
|
2
Berkshire Hathaway Class B
BRK.B
$1.14T
| $377K | 20.35% |
754
+27
| +4% | +$13K |
2023 Q4
10 quarters
|
|
|
3
Alphabet (Google) Class A
GOOGL
$4.21T
| $247K | 13.32% |
+691
| New | +$249K |
2026 Q2
0 quarters
|
|
|
4
Vanguard S&P 500 ETF
VOO
$1.04T
| $233K | 12.58% |
+339
| New | +$226K |
2026 Q2
0 quarters
|
|
|
5
Blackstone
BX
$85.5B
| $188K | 10.16% |
+1,597
| New | +$192K |
2026 Q2
0 quarters
|
|
|
6
Kyverna Therapeutics
KYTX
$361M
| $110K | 5.94% |
12,347
-6,426
| -34% | -$57K |
2024 Q1
9 quarters
|
|
|
7
Lexeo Therapeutics
LXEO
$227M
| $79K | 4.26% |
16,962
+3,019
| +22% | +$16.3K |
2023 Q4
10 quarters
|
|
8
X4 Pharmaceuticals
XFOR
$273M
| $72.6K | 3.92% |
15,557
| – | – |
2025 Q4
2 quarters
|
|
9
Inhibikase Therapeutics
IKT
$230M
| $57.8K | 3.12% |
28,453
| – | – |
2024 Q4
6 quarters
|
|
10
ALX Oncology
ALXO
$158M
| $43.4K | 2.34% |
20,946
| – | – |
2026 Q1
1 quarter
|
|
|
11
SPDR Gold Trust
GLD
$140B
| – | – |
-7,623
| Closed | -$3.28M | – |
|
Similar funds
1IC
MP
HGCK
CA
CAM
FLC
EW
DCM
Caxton Corporation's Q2 2026 Portfolio in Review
As of Q2 2026, Caxton Corporation held 11 positions worth $1.85M, down 54% from $4.02M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Caxton Corporation withdrew a net $2.64M in Q2 2026, closing 1 position and reducing 1 holding. Its most notable exit was SPDR Gold Trust, an estimated $3.28M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 82% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Caxton Corporation opened a new position in Alphabet (Google) Class A worth $247K.
- Caxton Corporation's largest Q2 2026 buy was Alphabet (Google) Class A: 691 shares worth $247K.
- Caxton Corporation added most to Lexeo Therapeutics in Q2 2026, an estimated $16.3K increase.
- Caxton Corporation's biggest Q2 2026 reduction was Kyverna Therapeutics, cutting an estimated $57K.
- Caxton Corporation fully exited SPDR Gold Trust in Q2 2026, selling an estimated $3.28M.
- Caxton Corporation's ten largest holdings make up 100% of its $1.85M portfolio in Q2 2026.
- Caxton Corporation opened 4 new positions and closed 1 in Q2 2026.
- Caxton Corporation's portfolio value fell 54% quarter-over-quarter to $1.85M.
Based on Caxton Corporation's 13F filing for Q2 2026, filed 14 Aug 2026.